Point72 Asset Management’s Akero Therapeutics AKRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145M | Buy |
2,710,929
+2,202,589
| +433% | +$118M | 0.28% | 65 |
|
|
2025
Q1 | $20.6M | Sell |
508,340
-391,340
| -43% | -$15.8M | 0.05% | 378 |
|
|
2024
Q4 | $25M | Sell |
899,680
-403,643
| -31% | -$11.2M | 0.06% | 346 |
|
|
2024
Q3 | $37.4M | Buy |
+1,303,323
| New | +$37.4M | 0.1% | 231 |
|
|
2024
Q2 | – | Sell |
-289,106
| Closed | -$7.3M | – | 1171 |
|
|
2024
Q1 | $7.3M | Sell |
289,106
-355,199
| -55% | -$8.97M | 0.02% | 668 |
|
|
2023
Q4 | $15M | Buy |
644,305
+605,705
| +1,569% | +$14.1M | 0.04% | 467 |
|
|
2023
Q3 | $1.95M | Buy |
+38,600
| New | +$1.95M | 0.01% | 827 |
|
|
2022
Q3 | – | Sell |
-2,300,000
| Closed | -$21.7M | – | 1019 |
|
|
2022
Q2 | $21.7M | Buy |
2,300,000
+453,000
| +25% | +$4.28M | 0.09% | 280 |
|
|
2022
Q1 | $26.2M | Buy |
1,847,000
+88,499
| +5% | +$1.26M | 0.1% | 238 |
|
|
2021
Q4 | $37.2M | Buy |
1,758,501
+360,101
| +26% | +$7.62M | 0.15% | 183 |
|
|
2021
Q3 | $31.3M | Buy |
1,398,400
+206,700
| +17% | +$4.62M | 0.14% | 192 |
|
|
2021
Q2 | $29.6M | Buy |
1,191,700
+685,203
| +135% | +$17M | 0.13% | 186 |
|
|
2021
Q1 | $14.7M | Sell |
506,497
-198,503
| -28% | -$5.76M | 0.07% | 324 |
|
|
2020
Q4 | $18.2M | Buy |
705,000
+561,861
| +393% | +$14.5M | 0.09% | 286 |
|
|
2020
Q3 | $4.41M | Sell |
143,139
-301,893
| -68% | -$9.29M | 0.02% | 544 |
|
|
2020
Q2 | $11.1M | Sell |
445,032
-280,213
| -39% | -$6.98M | 0.07% | 297 |
|
|
2020
Q1 | $15.4M | Buy |
725,245
+498,945
| +220% | +$10.6M | 0.12% | 234 |
|
|
2019
Q4 | $5.02M | Buy |
226,300
+119,600
| +112% | +$2.65M | 0.03% | 464 |
|
|
2019
Q3 | $2.43M | Buy |
106,700
+76,700
| +256% | +$1.74M | 0.01% | 516 |
|
|
2019
Q2 | $575K | Buy |
+30,000
| New | +$575K | ﹤0.01% | 733 |
|